Stock · ABBOTINDIA · Healthcare
ABBOTINDIA share price target 2026
Support, resistance, the F&O structure and the BazaarBaazi Crack Score for Abbott India Limited, refreshed every end-of-day run. A systematic, data-only read on Abbott India Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
The verdict
BazaarBaazi reads ABBOTINDIA as constructive with a Crack Score of 67/100 as of 25 Jul 2026.
BazaarBaaziSource & method
The scanner's readScanned · scanned 24 Jul 2026
Where ABBOTINDIA stands on the 500-name BazaarBaazi setup scanner: technicals, filed fundamentals and money flow read together, refreshed every run.
Scanned and scored this run, but the evidence is incomplete or conflicted. The engine fails closed to NO_TRADE.
Technical axis
90/100Fundamental axis
83/100Money flow
91/100Result pulse · Q4 FY26
58/100Technical evidence
money-flow score 91.2/100
Chaikin money flow +0.378 (accumulation)
up/down volume 1.44x (buyers dominant)
net +7 accumulation days (25d)
relative strength rising vs NIFTY
RS slope +13.9% (3m)
outperforming and above 50DMA
Fundamental evidence
cheaper than sector (0.78x median)
Red flags
above 200DMA (not a confirmed short-side trend)
strong accumulation tape
Relative valuation
P/E (TTM)
38.4P/E vs sector
+0.8%Sector percentile
32PEG
5.05Scanner levels from the deterministic engine run of 2026-07-24, not a SEBI-registered recommendation and not investment advice. The fundamental axis reads the official filing: Q4 FY26 result.
Price target: support and resistanceComputed 25 Jul 2026
Support and resistance for ABBOTINDIA are read inside the latest show; no spot was printed in the most recent editorial note.
Levels are read inside the latest show. The most recent editorial reference is Systematic Read on 21 Jul 2026.
These are structural reference lines, not a SEBI-registered price target. BazaarBaazi is independent media; the levels frame how the desk reads the ABBOTINDIA chart, refreshed every end-of-day run.
The Crack Score, and how it is built67 / 100 · Constructive
The Crack Score is a deterministic 0 to 100 conviction number. Here is exactly what moved it for ABBOTINDIA, so the figure is a transparent signal rather than a vibe.
Base 50, adjusted by the factors above and clamped to 0 to 100. How the Crack Score works.
The F&O viewHorizon · swing
How the futures and options structure on ABBOTINDIA reads right now.
The editorial price read on ABBOTINDIA is bullish. Strike-level option inventory is unavailable, so the page withholds writer, wall and pin claims. Single-stock F&O on ABBOTINDIA can be thinner than index F&O, so the desk weights price and filed evidence over raw OI. This is not a derivatives trade recommendation.
Why it movedLatest editorial line
The most recent BazaarBaazi read on what is driving ABBOTINDIA.
Systematic read: a disclosed, data-only model on real 1-year price structure.
Read in Systematic Read on 21 Jul 2026. Why ABBOTINDIA moved, the living explainer, tracks every move on one URL.
Latest filed resultsQ4 FY26
Abbott India Limited's most recent quarter, parsed straight from the official BSE filing. Every figure links back to its primary source.
Result Pulse
58 / 100Revenue
Rs 1,710 crNet profit
Rs 395 crEPS (quarter)
Rs 185.85| Growth | YoY | QoQ |
|---|---|---|
| Revenue | +6.5% | -0.8% |
| Net profit | +7.6% | +5.0% |
| Net margin | +23.1% | |
Figures are the Q4 FY26 result for Abbott India Limited, parsed straight from the official BSE integrated filing and verified to the paisa. The EPS shown is for the quarter, not a trailing-twelve-month figure, so it is not a P/E input.
Earnings history, every filed quarter31 quarters on record
Abbott India Limited's official quarterly revenue, EPS and Result Pulse trail, every quarter the desk holds from the verified filings export, back to 30 Jun 2018. These are quarterly facts, not TTM valuation inputs.
ABBOTINDIA official result trail
31 quarters
Quarterly figures only: revenue, net profit and EPS are copied from official filings. EPS here is not trailing twelve month EPS and is not used for valuation.
| Quarter | Revenue | EPS | PAT YoY | Pulse | Source |
|---|---|---|---|---|---|
| Q4 FY26ended 31 Mar 2026 / Standalone, audited | Rs 1,710 cr | Rs 185.85 | +7.6% | 58/100 | Filing |
| Q3 FY26ended 31 Dec 2025 / Standalone, audited | Rs 1,724 cr | Rs 176.92 | +4.2% | 58/100 | Filing |
| Q2 FY26ended 30 Sep 2025 / Standalone, audited | Rs 1,757 cr | Rs 195.42 | +15.8% | 73/100 | Filing |
| Q4 FY25ended 31 Mar 2025 / Standalone, audited | Rs 1,605 cr | Rs 172.72 | +27.9% | 95/100 | Filing |
| Q3 FY25ended 31 Dec 2024 / Standalone, audited | Rs 1,614 cr | Rs 169.78 | n/a | 58/100 | Filing |
| Q2 FY25ended 30 Sep 2024 / Standalone, audited | Rs 1,633 cr | Rs 168.76 | n/a | 58/100 | Filing |
| Q1 FY25ended 30 Jun 2024 / Standalone, audited | Rs 1,558 cr | Rs 154.36 | n/a | 58/100 | Filing |
| Q4 FY24ended 31 Mar 2024 / Standalone, audited | Rs 1,439 cr | Rs 565.28 | n/a | 58/100 | Filing |
| Q3 FY24ended 31 Dec 2023 / Standalone, audited | Rs 1,437 cr | Rs 146.34 | n/a | n/a | Filing |
| Q2 FY24ended 30 Sep 2023 / Standalone, audited | Rs 1,494 cr | Rs 147.27 | n/a | n/a | Filing |
| Q1 FY24ended 30 Jun 2023 / Standalone, audited | Rs 1,479 cr | Rs 136.58 | n/a | n/a | Filing |
| Q4 FY23ended 31 Mar 2023 / Standalone, audited | Rs 1,343 cr | Rs 108.90 | n/a | n/a | Filing |
| Q3 FY23ended 31 Dec 2022 / Standalone, audited | Rs 1,326 cr | Rs 116.16 | n/a | n/a | Filing |
| Q2 FY23ended 30 Sep 2022 / Standalone, audited | Rs 1,379 cr | Rs 124.95 | n/a | n/a | Filing |
| Q1 FY23ended 30 Jun 2022 / Standalone, audited | Rs 1,304 cr | Rs 96.77 | n/a | n/a | Filing |
| Q4 FY22ended 31 Mar 2022 / Standalone, audited | Rs 1,255 cr | Rs 99.49 | n/a | n/a | Filing |
| Q3 FY22ended 31 Dec 2021 / Standalone, audited | Rs 1,224 cr | Rs 93.74 | n/a | n/a | Filing |
| Q2 FY22ended 30 Sep 2021 / Standalone, audited | Rs 1,222 cr | Rs 90.51 | n/a | n/a | Filing |
| Q1 FY22ended 30 Jun 2021 / Standalone, audited | Rs 1,218 cr | Rs 92.12 | n/a | n/a | Filing |
| Q4 FY21ended 31 Mar 2021 / Standalone, audited | Rs 1,096 cr | Rs 71.75 | n/a | n/a | Filing |
| Q3 FY21ended 31 Dec 2020 / Standalone, audited | Rs 1,095 cr | Rs 83.36 | n/a | n/a | Filing |
| Q2 FY21ended 30 Sep 2020 / Standalone, audited | Rs 1,055 cr | Rs 85.05 | n/a | n/a | Filing |
| Q1 FY21ended 30 Jun 2020 / Standalone, audited | Rs 1,064 cr | Rs 84.87 | n/a | n/a | Filing |
| Q4 FY20ended 31 Mar 2020 / Standalone, audited | Rs 961 cr | Rs 52.22 | n/a | n/a | Filing |
| Q3 FY20ended 31 Dec 2019 / Standalone, audited | Rs 1,078 cr | Rs 87.85 | n/a | n/a | Filing |
| Q2 FY20ended 30 Sep 2019 / Standalone, audited | Rs 1,055 cr | Rs 83.92 | n/a | n/a | Filing |
| Q1 FY20ended 30 Jun 2019 / Standalone, audited | Rs 999 cr | Rs 55.03 | n/a | n/a | Filing |
| Q4 FY19ended 31 Mar 2019 / Standalone, audited | Rs 906 cr | Rs 53.28 | n/a | n/a | Filing |
| Q3 FY19ended 31 Dec 2018 / Standalone, audited | Rs 948 cr | Rs 55.08 | n/a | n/a | Filing |
| Q2 FY19ended 30 Sep 2018 / Standalone, audited | Rs 980 cr | Rs 64.79 | n/a | n/a | Filing |
| Q1 FY19ended 30 Jun 2018 / Standalone, audited | Rs 845 cr | Rs 38.78 | n/a | n/a | Filing |
The official financialsFiled to 31 Mar 2026
Abbott India Limited's statements as filed: trailing twelve month P&L, the balance sheet, and the cash engine. Parsed from official XBRL, shown in crore.
Trailing twelve months, on filed quarters
Revenue (TTM)
6,929 crNet profit (TTM)
1,552 crEBIT (TTM)
2,104 crProfit before tax (TTM)
2,079 crNet margin (TTM)
22.4%Finance costs (TTM)
25.0 crBalance sheet, as filed 2026-03-31
Total assets
6,502 crShareholder equity
4,774 crTotal borrowings
0.0 crCash and equivalents
442 crInventory
947 crTrade receivables
362 crThe cash engine, latest filed year
Operating cash flow
1,319 crCapex
40.9 crFree cash flow
1,278 crInvesting flow
371 crFinancing flow
1,066 crAnnual trail, filed year over filed year
| Year | Revenue | Net profit | Equity | Borrowings | CFO |
|---|---|---|---|---|---|
| FY26 | 6,929 cr | 1,552 cr | 4,774 cr | 0.0 cr | 1,319 cr |
| FY25 | 6,409 cr | 1,414 cr | 4,233 cr | 0.0 cr | 1,012 cr |
| FY24 | 5,849 cr | 1,201 cr | 3,699 cr | 0.0 cr | 1,213 cr |
| FY23 | 5,349 cr | 949 cr | 3,189 cr | 0.0 cr | 893 cr |
| FY22 | 4,919 cr | 799 cr | 2,820 cr | 0.0 cr | 948 cr |
| FY21 | 4,310 cr | 691 cr | 2,602 cr | 0.0 cr | n/a |
Every figure is parsed from Abbott India Limited's official NSE XBRL filings by the BazaarBaazi earnings lab and shown in crore rupees. Display data, not a valuation model input.
Management on record1 earnings call
Every ABBOTINDIA earnings call BazaarBaazi has indexed, latest 30 Sep 2022. Read management in its own words, straight from the filed transcript.
Abbott India Limited earnings calls on record
1 call since 30 Sep 2022
Each entry links to the transcript PDF the company filed with the exchange. Primary sources, in management's own words.
What changed1 disclosure
Every recent official filing from Abbott India Limited, straight from the exchange feed, with the BazaarBaazi Event Heat on the disclosure flow.
Abbott India Limited's most recent official filing is a Earnings dated 31 Mar 2026.
Event Heat
61 / 100Event Heat is a dated net read of Abbott India Limited's last 180 days of official disclosures, balancing the constructive filings against the ones to watch. It is a signal from what the company has filed, not investment advice. Every line above links to its official exchange filing, and the full market desk is at the disclosures hub.
Key fundamentalsEditorial reference
The anchor data BazaarBaazi references when reading the ABBOTINDIA chart. Not a substitute for a registered research note.
| Ticker | ABBOTINDIA |
|---|---|
| Full name | Abbott India Limited |
| Sector | Healthcare |
| Index class | MID CAP |
| ISIN | INE358A01014 |
| Market-cap band | ~61,200 cr (indicative) |
| Last referenced level | Inside latest show |
| Last session move | Not referenced this cycle |
| Editorial line in | Systematic Read on 21 Jul 2026 |
| Aliases tracked | ABBOTINDIA |
Reference chartLevels in show
The daily frame the desk reads on ABBOTINDIA.
FAQ11 reader questions · AEO-eligible
The line on ABBOTINDIA, distilled and schema-marked for AI Overview, Perplexity, and reader search.
What is the ABBOTINDIA share price target for 2026?
BazaarBaazi does not publish a SEBI-registered price target on ABBOTINDIA. The desk reads structural support and resistance inside each show against the printed spot; the most recent editorial line is Systematic Read on 21 Jul 2026.
What is BazaarBaazi's Crack Score for ABBOTINDIA?
The BazaarBaazi Crack Score for ABBOTINDIA is 67 out of 100 as of 25 Jul 2026, a constructive reading. It is a computed conviction number from the signed stance, how consistent the recent verdicts have been, the quality of the printed structure, and how fresh the review is. It is a transparency signal, not investment advice.
What is the F&O view on ABBOTINDIA?
Strike-level option inventory for ABBOTINDIA is unavailable, so BazaarBaazi withholds participant, direction and positioning claims. The editorial chart stance is not substituted for an option-chain observation.
What sector is ABBOTINDIA in and which peers does BazaarBaazi track?
ABBOTINDIA sits in Healthcare (mid cap), indicative market cap ~61,200 cr (indicative), ISIN INE358A01014. The peers BazaarBaazi reads alongside it are GLAND PHARMA LIMITED, Eris Lifesciences Limited, ACUTAAS CHEMICALS LIMITED. A systematic, data-only read on Abbott India Limited: where it trades versus its 50-day and 200-day lines, the live 52-week range, and momentum, refreshed from the scanner's real price series each run.
How often is the ABBOTINDIA view updated?
This page is one evergreen URL refreshed in place. The Crack Score and levels re-compute on every BazaarBaazi end-of-day run, and the dated stamp shows the last refresh. The latest signed verdict on ABBOTINDIA is bullish, published in Systematic Read on 21 Jul 2026.
Is ABBOTINDIA a qualifying setup on the BazaarBaazi scanner right now?
On the 2026-07-24 run of the 500-name BazaarBaazi setup scanner, Abbott India Limited sits in the Scanned tier with a setup score of 87/100 (technical 90, fundamental 83). The scanner is a deterministic engine over real OHLCV and official filings, refreshed nightly, and it is a signal rather than investment advice.
Where can I read Abbott India Limited's earnings call transcripts?
BazaarBaazi indexes 1 ABBOTINDIA earnings call going back to 2022-09-30, latest 2022-09-30. Every entry on this page links straight to the transcript PDF the company filed with the exchange, so you read management in the primary source.
What was Abbott India Limited's Q4 FY26 net profit?
Abbott India Limited reported a net profit of Rs 395 cr for Q4 FY26 (the quarter ended 31 March 2026). That is +7.6% year on year. The figure is from the company's official NSE filing.
What was Abbott India Limited's Q4 FY26 revenue?
Abbott India Limited reported revenue of Rs 1,710 cr for Q4 FY26. That is +6.5% year on year. The figure is from the company's official NSE filing.
How does BazaarBaazi rate Abbott India Limited's Q4 FY26 result?
BazaarBaazi gives Abbott India Limited's Q4 FY26 result a Result Pulse of 58 out of 100, with a verdict of Steady. The Result Pulse is a BazaarBaazi editorial score for the quality of the filed result, not investment advice.
What has Abbott India Ltd announced recently?
The most recent official filing on record for Abbott India Ltd is an earnings dated 31 Mar 2026. It is the company's own earnings disclosure to the exchange, and it links to that filing on the BazaarBaazi stock page rather than to any third-party summary.
Related stock views
The names BazaarBaazi reads alongside ABBOTINDIA, each a living view refreshed every end-of-day run.